n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Malignant Melanoma in 6 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sequential treatment of melanoma cells, first with gamma-irradiation to upregulate TRAIL-R surface expression, and then with resveratrol to suppress antiapoptotic proteins cFLIP and Bcl-xL and induce TRAIL surface expression, had dramatic effects on upregulation of apoptosis in some melanoma lines, including SW1 and WM35." | 1.35 | Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. ( Hei, TK; Ivanov, VN; Johnson, GE, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muraki, C | 1 |
| Ohga, N | 1 |
| Hida, Y | 1 |
| Nishihara, H | 1 |
| Kato, Y | 1 |
| Tsuchiya, K | 1 |
| Matsuda, K | 1 |
| Totsuka, Y | 1 |
| Shindoh, M | 1 |
| Hida, K | 1 |
| Duff, M | 1 |
| Stapleton, PP | 1 |
| Mestre, JR | 1 |
| Maddali, S | 1 |
| Smyth, GP | 1 |
| Yan, Z | 1 |
| Freeman, TA | 1 |
| Daly, JM | 1 |
| Denkins, Y | 1 |
| Kempf, D | 1 |
| Ferniz, M | 1 |
| Nileshwar, S | 1 |
| Marchetti, D | 1 |
| Ivanov, VN | 2 |
| Hei, TK | 2 |
| Johnson, GE | 1 |
| Denkert, C | 1 |
| Köbel, M | 1 |
| Berger, S | 1 |
| Siegert, A | 1 |
| Leclere, A | 1 |
| Trefzer, U | 1 |
| Hauptmann, S | 1 |
6 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Malignant Melanoma
| Article | Year |
|---|---|
Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
Topics: Animals; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cy | 2012 |
Cyclooxygenase-2 inhibition improves macrophage function in melanoma and increases the antineoplastic activity of interferon gamma.
Topics: Animals; Antineoplastic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibi | 2003 |
Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Cyclooxygenase 2; D | 2005 |
Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.
Topics: Apoptosis; Arsenites; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Therapy, | 2006 |
Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Chromones; Combined Modality Therapy; Cyclooxygena | 2008 |
Expression of cyclooxygenase 2 in human malignant melanoma.
Topics: Biocompatible Materials; Cell Division; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2001 |